{
  "primary": "NF-κB",
  "interaction_type": "indirect",
  "upstream_interactor": "IKK",
  "mediator_chain": [
    "IKK"
  ],
  "depth": 2,
  "support_summary": "HDAC6 indirectly regulates the transcriptional activity of NF-κB by deacetylating IKK, which is a key kinase that activates the NF-κB pathway.",
  "functions": [
    {
      "function": "NF-κB Transcriptional Activity (Nuclear Inhibition)",
      "arrow": "inhibits",
      "cellular_process": "In the nucleus, HDAC6 can directly interact with the p65/RelA subunit of the NF-κB complex. HDAC6 deacetylates p65, which reduces its ability to bind to the DNA promoter regions of its target genes.",
      "effect_description": "By deacetylating p65/RelA in the nucleus, HDAC6 acts as a direct transcriptional repressor of NF-κB target genes, such as the matrix metalloproteinase MMP2. This leads to decreased expression of genes involved in processes like cancer cell invasion.",
      "biological_consequence": [
        "Nuclear translocation of HDAC6 → Direct binding to the p65/RelA subunit of NF-κB → Deacetylation of p65 → Reduced DNA-binding affinity of NF-κB → Decreased transcription of target genes (e.g., MMP2) → Inhibition of cellular invasion"
      ],
      "specific_effects": [
        "Nuclear HDAC6 directly binds to and deacetylates the p65 subunit of NF-κB.",
        "Deacetylation of p65 by nuclear HDAC6 decreases its DNA-binding activity to the MMP2 promoter."
      ],
      "evidence": [
        {
          "paper_title": "Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer",
          "journal": "Oncotarget",
          "year": 2017,
          "relevant_quote": "The inhibitory effect of nuclear HDAC6 on invasion was mediated by the deacetylation of the p65 subunit of nuclear factor-κB, which decreased its DNA-binding activity to the MMP2 promoter, leading to the downregulation of MMP2 expression.",
          "pmid": "26388610"
        }
      ],
      "pathway": {
        "name": "NF-kappa B Signaling Pathway",
        "canonical_name": "Nf-Kappa B Signaling Pathway",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "26388610"
      ],
      "direct_arrow": "Not Applicable",
      "interaction_effect": "inhibits",
      "interaction_direction": "main_to_primary",
      "function_effect": "inhibition",
      "arrow_context": {
        "direct_from": "IKK",
        "direct_arrow": "Not Applicable",
        "net_from": "HDAC6",
        "net_arrow": "inhibits",
        "mediator_chain": [
          "IKK"
        ],
        "is_indirect": true
      },
      "net_arrow": "inhibits",
      "net_effect": "inhibition",
      "direct_effect": "Not Applicable"
    },
    {
      "function": "NF-κB Pathway Activation (Cytoplasmic)",
      "arrow": "activates",
      "cellular_process": "In the cytoplasm, HDAC6 is required for the activation of the canonical NF-κB pathway in response to stimuli like IL-1. The depletion of HDAC6 leads to an increase in the levels of the NF-κB inhibitor, IκBα, and prevents the nuclear translocation of NF-κB subunits.",
      "effect_description": "Contrary to acting as a suppressor in this context, cytoplasmic HDAC6 is a necessary component for the signaling cascade that leads to IκBα degradation. Therefore, HDAC6 activity promotes the release and nuclear translocation of NF-κB, thereby activating the transcription of its target genes, including those for MMPs and inflammatory cytokines.",
      "biological_consequence": [
        "Pro-inflammatory stimulus (e.g., IL-1) → HDAC6-dependent signaling cascade → Phosphorylation and degradation of IκBα → Release of NF-κB complex (p65/p50) → Nuclear translocation of NF-κB → Increased transcription of target genes (e.g., MMPs, cytokines)"
      ],
      "specific_effects": [
        "Depletion of HDAC6 post-transcriptionally up-regulated inhibitor of κB (IκB).",
        "Loss of HDAC6 prevented the nuclear translocation of NF-κB subunits and down-regulated NF-κB reporter activation."
      ],
      "evidence": [
        {
          "paper_title": "HDAC6 regulates NF-κB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression",
          "journal": "Scientific Reports",
          "year": 2022,
          "relevant_quote": "Depletion of HDAC6 post-transcriptionally up-regulated inhibitor of κB (IκB), prevented the nuclear translocation of NF-κB subunits and down-regulated NF-κB reporter activation.",
          "pmid": "35459919"
        }
      ],
      "pathway": {
        "name": "NF-kappa B Signaling Pathway",
        "canonical_name": "Nf-Kappa B Signaling Pathway",
        "ontology_id": null,
        "ontology_source": null,
        "confidence": 0.8
      },
      "pmids": [
        "35459919"
      ],
      "direct_arrow": "activates",
      "interaction_effect": "activates",
      "interaction_direction": "main_to_primary",
      "function_effect": "activation",
      "arrow_context": {
        "direct_from": "IKK",
        "direct_arrow": "activates",
        "net_from": "HDAC6",
        "net_arrow": "activates",
        "mediator_chain": [
          "IKK"
        ],
        "is_indirect": true
      },
      "net_arrow": "activates",
      "net_effect": "activation",
      "direct_effect": "activation"
    }
  ],
  "arrow": "regulates",
  "direction": "main_to_primary",
  "intent": "regulation",
  "arrows": {
    "main_to_primary": [
      "inhibits"
    ]
  },
  "is_valid": true,
  "mechanism_correction": "The input claim that HDAC6 universally inhibits NF-κB is a contextual error. The literature reveals a dual, location-dependent role. In the cytoplasm, HDAC6 is required for NF-κB activation by facilitating IκB degradation, which is the mechanistic opposite of the input's claim. In the nucleus, HDAC6 directly deacetylates the p65/RelA subunit, inhibiting its DNA-binding activity. The input correctly identified the nuclear mechanism but was incorrect about the cytoplasmic one.",
  "mechanism": "In the nucleus, HDAC6 can directly interact with the p65/RelA subunit of the NF-κB complex. HDAC6 deacetylates p65, which reduces its ability to bind to the DNA promoter regions of its target genes. In the cytoplasm, HDAC6 is required for the activation of the canonical NF-κB pathway in response to stimuli like IL-1. The depletion of HDAC6 leads to an increase in the levels of the NF-κB inhibitor, IκBα, and prevents the nuclear translocation of NF-κB subunits.",
  "effect": "By deacetylating p65/RelA in the nucleus, HDAC6 acts as a direct transcriptional repressor of NF-κB target genes, such as the matrix metalloproteinase MMP2. This leads to decreased expression of genes involved in processes like cancer cell invasion.; Contrary to acting as a suppressor in this context, cytoplasmic HDAC6 is a necessary component for the signaling cascade that leads to IκBα degradation. Therefore, HDAC6 activity promotes the release and nuclear translocation of NF-κB, thereby activating the transcription of its target genes, including those for MMPs and inflammatory cytokines.",
  "summary": "HDAC6 regulates NF-κB to regulate nf-κb transcriptional activity (nuclear inhibition) and nf-κb pathway activation (cytoplasmic), ultimately affecting inhibition of cellular invasion.",
  "evidence": [
    {
      "paper_title": "Nuclear HDAC6 inhibits invasion by suppressing NF-κB/MMP2 and is inversely correlated with metastasis of non-small cell lung cancer",
      "journal": "Oncotarget",
      "year": 2017,
      "relevant_quote": "The inhibitory effect of nuclear HDAC6 on invasion was mediated by the deacetylation of the p65 subunit of nuclear factor-κB, which decreased its DNA-binding activity to the MMP2 promoter, leading to the downregulation of MMP2 expression."
    },
    {
      "paper_title": "HDAC6 regulates NF-κB signalling to control chondrocyte IL-1-induced MMP and inflammatory gene expression",
      "journal": "Scientific Reports",
      "year": 2022,
      "relevant_quote": "Depletion of HDAC6 post-transcriptionally up-regulated inhibitor of κB (IκB), prevented the nuclear translocation of NF-κB subunits and down-regulated NF-κB reporter activation."
    }
  ],
  "pathways": [
    {
      "name": "NF-kappa B Signaling Pathway",
      "canonical_name": "Nf-Kappa B Signaling Pathway",
      "ontology_id": null,
      "ontology_source": null,
      "confidence": 0.8
    }
  ],
  "interaction_effect": "regulation",
  "_validation_metadata": {
    "validated": true,
    "validator": "arrow_effect_validator",
    "corrections_applied": 2
  },
  "_arrow_validated": true,
  "arrow_notation": "IKK --regulates--> NF-κB:",
  "protein_a": "HDAC6",
  "protein_b": "NF-κB",
  "discovered_in_query": "HDAC6",
  "first_discovered": "2025-12-04T16:37:52.736835Z",
  "last_updated": "2025-12-04T16:37:52.736835Z"
}